These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells. Bäckström M; Link T; Olson FJ; Karlsson H; Graham R; Picco G; Burchell J; Taylor-Papadimitriou J; Noll T; Hansson GC Biochem J; 2003 Dec; 376(Pt 3):677-86. PubMed ID: 12950230 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. Brockhausen I; Yang JM; Burchell J; Whitehouse C; Taylor-Papadimitriou J Eur J Biochem; 1995 Oct; 233(2):607-17. PubMed ID: 7588808 [TBL] [Abstract][Full Text] [Related]
5. The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient's serum. Storr SJ; Royle L; Chapman CJ; Hamid UM; Robertson JF; Murray A; Dwek RA; Rudd PM Glycobiology; 2008 Jun; 18(6):456-62. PubMed ID: 18332077 [TBL] [Abstract][Full Text] [Related]
6. MUC1 glycoforms in breast cancer--cell line T47D as a model for carcinoma-associated alterations of 0-glycosylation. Hanisch FG; Stadie TR; Deutzmann F; Peter-Katalinic J Eur J Biochem; 1996 Feb; 236(1):318-27. PubMed ID: 8617281 [TBL] [Abstract][Full Text] [Related]
7. High density O-glycosylation on tandem repeat peptide from secretory MUC1 of T47D breast cancer cells. Müller S; Alving K; Peter-Katalinic J; Zachara N; Gooley AA; Hanisch FG J Biol Chem; 1999 Jun; 274(26):18165-72. PubMed ID: 10373415 [TBL] [Abstract][Full Text] [Related]
8. MUC1 and cancer. Taylor-Papadimitriou J; Burchell J; Miles DW; Dalziel M Biochim Biophys Acta; 1999 Oct; 1455(2-3):301-13. PubMed ID: 10571020 [TBL] [Abstract][Full Text] [Related]
9. The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer. Sewell R; Bäckström M; Dalziel M; Gschmeissner S; Karlsson H; Noll T; Gätgens J; Clausen H; Hansson GC; Burchell J; Taylor-Papadimitriou J J Biol Chem; 2006 Feb; 281(6):3586-94. PubMed ID: 16319059 [TBL] [Abstract][Full Text] [Related]
10. Evidence for core 2 to core 1 O-glycan remodeling during the recycling of MUC1. Razawi H; Kinlough CL; Staubach S; Poland PA; Rbaibi Y; Weisz OA; Hughey RP; Hanisch FG Glycobiology; 2013 Aug; 23(8):935-45. PubMed ID: 23640779 [TBL] [Abstract][Full Text] [Related]
11. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity. Irimura T; Denda K; Iida Si; Takeuchi H; Kato K J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046 [TBL] [Abstract][Full Text] [Related]
12. A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2-based O-glycans. Whitehouse C; Burchell J; Gschmeissner S; Brockhausen I; Lloyd KO; Taylor-Papadimitriou J J Cell Biol; 1997 Jun; 137(6):1229-41. PubMed ID: 9182658 [TBL] [Abstract][Full Text] [Related]
13. Sialylated core 1 based O-linked glycans enhance the growth rate of mammary carcinoma cells in MUC1 transgenic mice. Mungul A; Cooper L; Brockhausen I; Ryder K; Mandel U; Clausen H; Rughetti A; Miles DW; Taylor-Papadimitriou J; Burchell JM Int J Oncol; 2004 Oct; 25(4):937-43. PubMed ID: 15375543 [TBL] [Abstract][Full Text] [Related]
14. N-Glycosylation of the MUC1 mucin in epithelial cells and secretions. Parry S; Hanisch FG; Leir SH; Sutton-Smith M; Morris HR; Dell A; Harris A Glycobiology; 2006 Jul; 16(7):623-34. PubMed ID: 16585136 [TBL] [Abstract][Full Text] [Related]
15. A MUC1 tandem repeat reporter protein produced in CHO-K1 cells has sialylated core 1 O-glycans and becomes more densely glycosylated if coexpressed with polypeptide-GalNAc-T4 transferase. Olson FJ; Bäckström M; Karlsson H; Burchell J; Hansson GC Glycobiology; 2005 Feb; 15(2):177-91. PubMed ID: 15456735 [TBL] [Abstract][Full Text] [Related]
16. MUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 β1,6-N-acetylglucosaminyltransferase and β-galactoside α2,3-sialyltransferase. Solatycka A; Owczarek T; Piller F; Piller V; Pula B; Wojciech L; Podhorska-Okolow M; Dziegiel P; Ugorski M Glycobiology; 2012 Aug; 22(8):1042-54. PubMed ID: 22534569 [TBL] [Abstract][Full Text] [Related]
17. Top-down sequencing of O-glycoproteins by in-source decay matrix-assisted laser desorption ionization mass spectrometry for glycosylation site analysis. Hanisch FG Anal Chem; 2011 Jun; 83(12):4829-37. PubMed ID: 21526855 [TBL] [Abstract][Full Text] [Related]
18. Site directed processing: role of amino acid sequences and glycosylation of acceptor glycopeptides in the assembly of extended mucin type O-glycan core 2. Brockhausen I; Dowler T; Paulsen H Biochim Biophys Acta; 2009 Oct; 1790(10):1244-57. PubMed ID: 19524017 [TBL] [Abstract][Full Text] [Related]
19. O-linked mucin-type glycosylation regulates the transcriptional programme downstream of EGFR. Tajadura-Ortega V; Gambardella G; Skinner A; Halim A; Van Coillie J; Schjoldager KTG; Beatson R; Graham R; Achkova D; Taylor-Papadimitriou J; Ciccarelli FD; Burchell JM Glycobiology; 2021 Apr; 31(3):200-210. PubMed ID: 32776095 [TBL] [Abstract][Full Text] [Related]
20. The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1. Dalziel M; Whitehouse C; McFarlane I; Brockhausen I; Gschmeissner S; Schwientek T; Clausen H; Burchell JM; Taylor-Papadimitriou J J Biol Chem; 2001 Apr; 276(14):11007-15. PubMed ID: 11118434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]